Eye on Ocular Health

Personalized care is playing a bigger role in geographic atrophy management, especially as emerging therapies are giving clinicians more opportunities to help slow disease progression. To choose the right approach, it’s important to consider various factors, such as lesion characteristics, treatment burden, and each patient’s individual goals and lifestyle. Joining Dr. Charles Turck to share practical insights on tailoring treatment decisions and guiding patient conversations around geographic atrophy care is Dr. Jonathan Jonisch, board-certified ophthalmologist and Assistant Clinical Professor of Ophthalmology at the Hofstra Northwell School of Medicine in New York.

Geographic atrophy can progress silently before patients notice meaningful vision changes, making early detection critical to preserving long-term retinal health. Fortunately, advances in imaging and emerging biomarkers are helping clinicians identify higher-risk patients earlier and refine monitoring and referral decisions. Joining Dr. Alexandria May to discuss the evolving approach to geographic atrophy detection and management is Dr. Hasenin Al-khersan, a board-certified medical and surgical retina specialist with Retina Consultants of Texas in Houston.

Geographic atrophy can develop long before traditional visual acuity testing reflects the true impact of disease, making early identification critical in patients with age-related macular degeneration (AMD). In this discussion with Dr. Brian McDonough, Dr. Jaclyn Kovach reviews the imaging findings and biologic drivers associated with geographic atrophy progression and shares practical approaches to patient monitoring. Dr. Kovach is a Professor of Clinical Ophthalmology and the Fellowship Director at the University of Miami Miller School of Medicine's Bascom Palmer Eye Institute.

Dive into what sets metastatic uveal melanoma (mUM) apart from cutaneous melanoma and why that matters for clinical decision-making. Explore how HLA A*02:01 typing informs patient selection and how bispecific TCR therapy is changing the treatment landscape. Real-world cases and clinical trial data bring these concepts to life, with special attention to application in VA and academic settings. Whether you're a medical oncologist, ocular oncologist, ophthalmologist, or APP, this discussion is designed to sharpen your skills and your care aligned with the latest science.

Emerging evidence reveals that air pollution may be an overlooked contributor to worsening uncorrected visual acuity in children. In this AudioAbstract, Ryan Quigley explores a large machine learning–based study examining nearly 30,000 East Asian students that revealed lower levels of PM2.5 and nitrogen dioxide are independently linked to better vision—especially in younger children with mild to moderate myopia.

Listen to Dr. Eric Ritchey explain how he introduces MiSight® 1 day to parents—highlighting its safety, comfort, and dual benefits—and emphasizes the importance of daily disposables for hygiene and the long-term eye health advantages of managing myopia early in children.

In this short video, Dr. Shelia Morrison explains how she introduces parents to myopia management by emphasizing that today's treatment options—like MiSight® 1 day—can both correct vision and slow myopia progression during critical growth periods. She highlights the importance of early intervention and presents daily disposable lenses as a safe, effective solution for active children.

Dr. Ariel Cerenzie shares quick tips on how she communicates the urgency of myopia progression to parents and introduces MiSight® 1 day as a proactive solution. She explains that the lenses not only correct vision but also therapeutically slow myopia progression, offering a meaningful way to protect a child’s long-term eye health.

In this short video, Dr. Ashley Tucker shares how she talks to parents about myopia management, emphasizing that myopia is more than just blurry vision; it’s a progressive condition that can lead to serious eye health risks. She introduces MiSight® 1 day as a dual-purpose option that not only corrects vision, but also helps slow the progression of myopia in age-appropriate children.

Many eye care professionals and parents still believe children must wait until their teenage years to wear contact lenses, but as Dr. Jeffrey Walline explains, modern daily disposable lenses offer improved safety, comfort, and ease of use, making them a viable option for children as young as 7 or 8. And beyond the clinical benefits of slowing myopia progression and preserving long-term eye health, contact lenses have also been shown to improve children’s self-esteem. Learn more with Dr. Walline, Associate Dean of Academic Affairs at The Ohio State University College of Optometry.